Rocket Lab shares fall 2.16% despite $266M Space Force contract
Rocket Lab Corp shares declined to $62.51 on Wednesday, continuing a downtrend that began after the announcement of a $266 million U.S. Space Force contract for 12 suborbital launches. Despite the deal's long-term value, technical indicators remain bearish, with the stock trading below its 20-day, 50-day, and 200-day moving averages.

*this image is generated using AI for illustrative purposes only.
Rocket Lab Corp shares declined 2.16% to $62.51 on Wednesday morning, extending a broader selloff that has persisted since the company announced a $266 million U.S. Space Force contract earlier in the week. The downward pressure reflects ongoing risk-off market sentiment, which continues to overshadow the fundamental value of the deal. Investors appear cautious about the timing of revenue recognition, as missions under the contract are not expected to begin until late 2026.
The stock’s performance highlights a divergence between corporate news and market positioning. While the contract provides long-term visibility, immediate technical weakness has kept the stock trapped below critical moving averages. The decline pushes Rocket Lab’s shares further from their recent highs, signaling that short-term traders are prioritizing liquidity over the multi-year execution timeline of the Space Force program.
Contract Details
The firm-fixed-price agreement covers 12 suborbital launches managed by the Space Systems Command’s Rocket Systems Launch Program. Work will be conducted primarily at the Pacific Spaceport Complex-Alaska (PSCA) in Kodiak. The contract includes options for six additional High Altitude Suborbital Target Emulator (HASTE) missions, bringing the total potential volume to 18 launches. Fiscal 2025 research, development, test and evaluation funds totaling $112 million are obligated at award, with full completion expected by Dec. 31, 2028.
| Contract Component | Details |
|---|---|
| Total Value | $266 million |
| Confirmed Launches | 12 |
| Optional Launches | 6 |
| Performance Location | Pacific Spaceport Complex, Alaska |
| Completion Date | Dec. 31, 2028 |
| Funds Obligated | $112 million |
Technical Outlook
Rocket Lab’s stock is currently in "repair mode," trading 18.9% below its 20-day simple moving average (SMA) of $78.08 and 18.6% below its 200-day SMA of $77.82. The stock remains significantly below its 50-day SMA of $100.66, indicating that intermediate momentum has been severely impacted. Key resistance sits at $75.00, a round-number area just below the 20-day average zone where rebounds may stall due to overhead supply. Support is identified at $56.00, a prior demand area that serves as a key reference if the pullback extends.
Momentum indicators reinforce the negative price action. The Moving Average Convergence Divergence (MACD) is below its signal line with a negative histogram, suggesting fading upside pressure. Although the 50-day SMA remains above the 200-day SMA — preserving a bullish longer-term backdrop — the structure has been damaged by recent selling. The stock had previously logged a 52-week high of $151.00 in May before breaking below support in December 2025 and printing a swing low in July.
What the Numbers Show
The divergence between the substantial contract value and the immediate share price decline suggests that macro market conditions are currently outweighing company-specific fundamentals. While the $266 million deal provides long-term revenue visibility, the technical breakdown below all major moving averages indicates that short-term traders are prioritizing liquidity and risk management over the multi-year execution timeline of the Space Force program.
How might the delayed revenue recognition timeline, with missions starting in late 2026, impact Rocket Lab's near-term cash flow and valuation multiples?
What specific catalysts would be required to break the current technical resistance at $75.00 and restore investor confidence in the stock's momentum?
Could the broader 'risk-off' market sentiment persist long enough to negate the strategic value of the Space Force contract for institutional investors?

































